Trending...
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- 'Unity Through Christ Music Festival' coming to Detroit Saturday August 9, 2025
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, Inc., a medical device company developing retinal imagers to detect early disease by assessing retinal metabolic activity, today announced the publication of a rare inherited mitochondrial diseases study in Ophthalmology Genetics journal. These findings suggest that the novel FPF measure can differentiate between patients diagnosed with inherited retinal dystrophies and their age-matched controls. Furthermore, the FPF results correlated with fundus autofluorescence findings, suggesting clinical utility of the rapid, automated measure.
This observational study, led by Elias Traboulsi, M.D., M.Ed., Director of the Center for Genetic Eye Diseases at Cleveland Clinic Cole Eye Institute, included 157 patients with genetically confirmed rod-cone dystrophy, Stargardt disease, Bardet-Biedl syndrome (BBS), and Mitochondrial ATP synthase mutation. Patients were imaged with the OcuMet Beacon, OcuSciences' flagship functional retinal imager, between January and December 2021 to capture and quantify their FPF signal. Mean FPF intensity and heterogeneity was significantly higher in patients with inherited retinal dystrophies than age-matched controls.
More on Michimich.com
"These findings suggest that flavoprotein fluorescence could be used as an additional tool in the assessment and diagnosis of patients with inherited retinal dystrophies," said Dr. Traboulsi. "More studies are needed that will help elucidate how this imaging modality could be implemented clinically and if there are opportunities to use FPF as a monitoring tool in these types of diseases."
The OcuMet Beacon is an automated, rapid retinal imager that assesses mitochondrial function by interrogating flavoproteins. The device emits a very specific wavelength of light that selectively excites flavoproteins in retinal mitochondria that are dysfunctional and hence cannot efficiently produce ATP. The flavoproteins in dysfunctional mitochondria emit a specific wavelength that the device then captures and quantifies. Mitochondrial dysfunctional has been documented as a precursor to apoptosis, or cell death.
The OcuMet Beacon is currently being used under Institutional Review Board at Cole Eye Institute.
About OcuSciences, Inc.
OcuSciences, Inc., is a commercial-stage biotechnology company developing retinal imagers to identify metabolic dysfunction occurring in the retina for the early detection of disease. Its flagship device, the OcuMet Beacon, has being developed to automatically and non-invasively assess retinal metabolic function by detecting the degree of flavoprotein fluorescence (FPF), a well-studied precursor to retinal cell death, in a patient's eye. OcuSciences has shown preliminary clinical utility in a number of different disease states, including diabetic retinopathy, glaucoma, and age-related macular degeneration. Learn more at www.ocusciences.com.
More on Michimich.com
Contacts
Kurt Riegger
(734) 623-9434
info@ocusciences.com
This observational study, led by Elias Traboulsi, M.D., M.Ed., Director of the Center for Genetic Eye Diseases at Cleveland Clinic Cole Eye Institute, included 157 patients with genetically confirmed rod-cone dystrophy, Stargardt disease, Bardet-Biedl syndrome (BBS), and Mitochondrial ATP synthase mutation. Patients were imaged with the OcuMet Beacon, OcuSciences' flagship functional retinal imager, between January and December 2021 to capture and quantify their FPF signal. Mean FPF intensity and heterogeneity was significantly higher in patients with inherited retinal dystrophies than age-matched controls.
More on Michimich.com
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- Colbert Packaging Announces WBENC Recognition
- DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
- Assent Expands Executive Team to Accelerate Global Growth & Innovation
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
"These findings suggest that flavoprotein fluorescence could be used as an additional tool in the assessment and diagnosis of patients with inherited retinal dystrophies," said Dr. Traboulsi. "More studies are needed that will help elucidate how this imaging modality could be implemented clinically and if there are opportunities to use FPF as a monitoring tool in these types of diseases."
The OcuMet Beacon is an automated, rapid retinal imager that assesses mitochondrial function by interrogating flavoproteins. The device emits a very specific wavelength of light that selectively excites flavoproteins in retinal mitochondria that are dysfunctional and hence cannot efficiently produce ATP. The flavoproteins in dysfunctional mitochondria emit a specific wavelength that the device then captures and quantifies. Mitochondrial dysfunctional has been documented as a precursor to apoptosis, or cell death.
The OcuMet Beacon is currently being used under Institutional Review Board at Cole Eye Institute.
About OcuSciences, Inc.
OcuSciences, Inc., is a commercial-stage biotechnology company developing retinal imagers to identify metabolic dysfunction occurring in the retina for the early detection of disease. Its flagship device, the OcuMet Beacon, has being developed to automatically and non-invasively assess retinal metabolic function by detecting the degree of flavoprotein fluorescence (FPF), a well-studied precursor to retinal cell death, in a patient's eye. OcuSciences has shown preliminary clinical utility in a number of different disease states, including diabetic retinopathy, glaucoma, and age-related macular degeneration. Learn more at www.ocusciences.com.
More on Michimich.com
- Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
- Centennial Flyers to Become Colorado's First Launch Customer for All-Electric B23 Energic Aircraft
- Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
- Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
- $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
Contacts
Kurt Riegger
(734) 623-9434
info@ocusciences.com
Filed Under: Business
0 Comments
Latest on Michimich.com
- BIYA Forecasts 2025 Surge with ¥300M ($41.8 M USD) in Revenue and ¥25M Profit from Cloud Based HR Solutions: Baiya Intl. Group (N A S D A Q: BIYA)
- Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
- CMR Mechanical Shares 5 Signs Your AC May Be in Desperate Need for Repair
- Michigan SEO Group Shares 5 Proven Ways to Boost Social Media Engagement for Small Businesses
- Mussio Painting Shares The Benefits of Working with Professional Painters in Ann Arbor
- Family Caregivers in Michigan Can Now Get Paid Through Medicaid with Family Aide Home Care
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- Hillside Terrace Champions Lifelong Learning in Assisted Living
- Veteran Criminal Defense Attorney Offers Strategic DUI Defense and License Reinstatement
- Ann Arbor Criminal Defense Attorney Urges Residents to Be Informed During Police Encounters
- ArborMotion Highlights the Importance of Timely Brake Replacement for European Vehicles
- EASTSIDE GOLF OPENS FIRST U.S. STOREFRONT IN DETROIT